||Selective / Pan
||IC50 / Ki
||Avagacestat (BMS-708163) is a potent, selective, orally bioavailable γ-secretase inhibitor of Aβ40 and Aβ42 with IC50 of 0.3 nM and 0.27 nM, demonstrating a 193-fold selectivity against Notch. Phase 2.
||γ secretase(Aβ42), IC50: 0.27 nM; γ secretase(Aβ40), IC50: 0.3 nM
||DAPT (GSI-IX) is a novel γ-secretase inhibitor, which inhibits Aβ production with IC50 of 20 nM in HEK 293 cells.
||γ secretase(Aβ), IC50: 20 nM
||MK-0752 is a moderately potent γ-secretase inhibitor, which reduces Aβ40 production with IC50 of 5 nM. Phase 1/2.
||Semagacestat (LY450139) is a γ-secretase blocker for Aβ42, Aβ40 and Aβ38 with IC50 of 10.9 nM, 12.1 nM and 12.0 nM, also inhibits Notch signaling with IC50 of 14.1 nM. Phase 3.
||γ secretase(Aβ38), IC50: 12.0 nM; γ secretase(Aβ42), IC50: 10.9 nM; γ secretase(Aβ40), IC50: 12.1 nM